Advanced search
Publication Cover
International Journal of Psychiatry in Clinical Practice Volume 19, 2015 - Issue 3
Submit an article Journal homepage
309
Views
12
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Anhedonia in depressed patients on treatment with selective serotonin reuptake inhibitor anti-depressant—A two-centered study in Malaysia

Anne YeeDepartment of Psychological Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
,
Soo Cheng ChinDepartment of Psychiatry, Hospital Sultanah Nora Ismail, Batu Pahat, Johor, Malaysia
,
Aili Hanim bt HashimDepartment of Psychological Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
,
Manveen Kaur A/P Harbajan SinghDepartment of Psychological Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
,
Huai Seng LohClinical Academic Unit (Family Medicine), Newcastle University Medicine Malaysia, Johor, MalaysiaCorrespondence[email protected]
,
Ahmad Hatim SulaimanDepartment of Psychological Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
&
Chong Guan NgDepartment of Psychological Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
 show all
Pages 182-187 | Received 23 Jun 2014, Accepted 28 Feb 2015, Published online: 15 Apr 2015

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Roger S McIntyre, Henrik Loft & Michael Cronquist Christensen. (2021) Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder. Neuropsychiatric Disease and Treatment 17, pages 575-585.
Read now

Articles from other publishers (11)

Dominika Dudek, Adrian Andrzej Chrobak, Anna Julia Krupa, Aleksandra Gorostowicz, Adrian Gerlich, Andrzej Juryk & Marcin Siwek. (2023) TED—trazodone effectiveness in depression: a naturalistic study of the effeciveness of trazodone in extended release formulation compared to SSRIs in patients with a major depressive disorder. Frontiers in Pharmacology 14.
Crossref
Koichiro Watanabe, Shinji Fujimoto, Tatsuro Marumoto, Tadayuki Kitagawa, Kazuyuki Ishida, Tadashi Nakajima, Yoshiya Moriguchi, Keita Fujikawa & Takeshi Inoue. (2022) Therapeutic Potential of Vortioxetine for Anhedonia-Like Symptoms in Depression: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan. Neuropsychiatric Disease and Treatment Volume 18, pages 363-373.
Crossref
Taylor KuhnJonathan HaroonNorman M. Spivak. (2022) A Systematic Approach to Neuropsychiatric Intervention: Functional Neuroanatomy Underlying Symptom Domains as Targets for Treatment. FOCUS 20:1, pages 45-54.
Crossref
Edgar Wing-ka Ching, Tin Po Chiang, Jessica O. Y. Wong, Bonnie W. M. Siu, Koi Man Cheng, Simon S. Y. Lui & Eric F. C. Cheung. (2021) Validation of the Chinese Dimensional Anhedonia Rating Scale in Depressed Patients in Hong Kong. Psychological Test Adaptation and Development 2:1, pages 72-79.
Crossref
Viktoriya Nikolova, Anthony Cleare, Allan Young & James Stone. (2021) Updated Review and Meta-Analysis of Probiotics for the Treatment of Clinical Depression: Adjunctive vs. Stand-Alone Treatment. Journal of Clinical Medicine 10:4, pages 647.
Crossref
Yu Sun, Wayne Drevets, Gustavo Turecki & Qingqin S. Li. (2020) The relationship between plasma serotonin and kynurenine pathway metabolite levels and the treatment response to escitalopram and desvenlafaxine. Brain, Behavior, and Immunity 87, pages 404-412.
Crossref
Kymberly D. Young, Edward S. Friedman, Amanda Collier, Susan R. Berman, Joshua Feldmiller, Agnes E. Haggerty, Michael E. Thase & Greg J. Siegle. (2020) Response to SSRI intervention and amygdala activity during self-referential processing in major depressive disorder. NeuroImage: Clinical 28, pages 102388.
Crossref
Laura Mandelli, Alessandro Serretti, Stefano Porcelli, Daniel Souery, Julien Mendlewicz, Siegfried Kasper, Stuart Montgomery & Joseph Zohar. (2018) Opinion paper: poor response to treatment of depression in people in high occupational levels. Psychological Medicine 49:1, pages 49-54.
Crossref
Jan Józef Szczypiński & Mateusz Gola. (2018) Dopamine dysregulation hypothesis: the common basis for motivational anhedonia in major depressive disorder and schizophrenia?. Reviews in the Neurosciences 29:7, pages 727-744.
Crossref
Fionneke M. Bos, Eiko I. Fried, Steven D. Hollon, Laura F. Bringmann, Sona Dimidjian, Robert J. DeRubeis & Claudi L. H. Bockting. (2018) Cross-sectional networks of depressive symptoms before and after antidepressant medication treatment. Social Psychiatry and Psychiatric Epidemiology 53:6, pages 617-627.
Crossref
F.M. Bos, F.J. Blaauw, E. Snippe, L. van der Krieke, P. de Jonge & M. Wichers. (2018) Exploring the emotional dynamics of subclinically depressed individuals with and without anhedonia: An experience sampling study. Journal of Affective Disorders 228, pages 186-193.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.